About Polymedicure
Polymedicure is a company based in Delhi (India) founded in 1995 by Himanshu Baid. The company has 3,080 employees as of March 31, 2024. Polymedicure has completed 2 acquisitions, including Citieffe and Plan 1 Health. Polymedicure offers products and services including Oncology Devices and Infusion Therapy Products.
- Headquarter Delhi, India
- Employees 3080 as on 31 Mar, 2024
- Founders Himanshu Baid
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Poly Medicure Limited
-
Annual Revenue
$193.95 M (USD)21.15as on Mar 31, 2025
-
Net Profit
$39.68 M (USD)31.09as on Mar 31, 2025
-
EBITDA
$52.79 M (USD)25.1as on Mar 31, 2025
-
Latest Funding Round
$119.23 M (USD), Post-IPO
Aug 19, 2024
-
Investors
UTI Mutual Fund
& 3 more
-
Employee Count
3080
as on Mar 31, 2024
-
Investments & Acquisitions
Citieffe
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Polymedicure
Polymedicure is a publicly listed company on the NSE with ticker symbol POLYMED in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Polymedicure
Polymedicure offers a comprehensive portfolio of products and services, including Oncology Devices and Infusion Therapy Products.
Specialized devices for chemotherapy are manufactured by Polymed to support treatment in oncology.
Products for IV therapy are provided by Polymed to enhance safety and convenience in healthcare settings.
People of Polymedicure
Unlock access to complete
Funding Insights of Polymedicure
Investors in Polymedicure
Polymedicure has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include UTI Mutual Fund, Max Life Insurance and Abu Dhabi Investment Authority.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funds for Indian startups are managed by Lighthouse.
|
Locked | Locked | Locked | |
|
Mutual funds, portfolio management, and retirement planning services are offered.
|
Locked | Locked | Locked | |
|
Life insurance plans and policies are offered for protection.
|
Locked | Locked | Locked |
Investor details for Polymedicure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polymedicure
Polymedicure has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Citieffe and Plan 1 Health.
Investment portfolio details for Polymedicure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Dental implant devices and accessories are supplied to professionals.
|
Locked | Locked | 2001 | Locked | |
|
Orthopedic fixation systems for limb and pelvis fractures are developed.
|
Locked | Locked | 1962 | Locked |
Complete acquisition details for Polymedicure
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Polymedicure
Detailed financials for Polymedicure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polymedicure Comparisons
Peer comparison for Polymedicure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polymedicure
Detailed competitors of Polymedicure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polymedicure
Complete news archive for Polymedicure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polymedicure
Polymedicure was founded in 1995 and raised its 1st funding round 26 years after it was founded.
Polymedicure is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Mar 31, 2024, the latest employee count at Polymedicure is 3,080.
Annual revenue of Polymedicure is $193.95M as on Mar 31, 2025.
Polymedicure was founded in 1995 and is headquartered in Delhi, India. Operations are centered on the production of medical devices within the healthcare sector, including infusion therapy devices, blood management systems, and wound drainage equipment. These products support oncology, dialysis, and respiratory care applications. Manufacturing occurs in facilities equipped with advanced technology to meet quality standards.
Polymedicure offers Oncology Devices and Infusion Therapy Products.
Yes, Polymedicure is publicly traded on NSE under the ticker symbol POLYMED.
Polymedicure has made 2 acquisitions, including Citieffe, and Plan 1 Health.
Polymedicure has 4 investors. Key investors include UTI Mutual Fund, Max Life Insurance, Abu Dhabi Investment Authority, and Lighthouse Funds.
The ticker symbol of Polymedicure is POLYMED on NSE.